Literature DB >> 12585635

The outcome of varicose vein surgery at 10 years: clinical findings, symptoms and patient satisfaction.

W B Campbell1, A Vijay Kumar, T W Collin, K L Allington, J A Michaels.   

Abstract

BACKGROUND: Data on long-term outcomes of varicose vein surgery are sparse, and 'success' rates vary substantially depending on the method of assessment. This study used a variety of methods to evaluate patients 10 years after operation.
METHODS: A consecutive cohort of 100 patients was identified, of whom 70 (151 operated limbs) were reviewed--50 by clinical and Doppler examination, and all by structured questionnaire.
RESULTS: A few months after operation, symptoms were 'cured' or 'much better' in 89% of patients, and remained so at 10 years in 77%. Only 30% patients were completely free of recurrent varicose veins at 10 years (both by self- and clinician-assessment): 44% had 'just a few' varicosities while 26%, had varicose veins 'as badly as before'. Only 24 patients (34%) were not 'generally pleased' at 10 years, because of continuing symptoms (3), recurrent varicosities (13), and other miscellaneous reasons.
CONCLUSIONS: Although some recurrence of varicose veins is frequent 10 years after operation, surgery provides long-term relief of symptoms in the great majority of patients.

Entities:  

Mesh:

Year:  2003        PMID: 12585635      PMCID: PMC1964354          DOI: 10.1308/003588403321001462

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  10 in total

Review 1.  Varicose veins and their management.

Authors:  Bruce Campbell
Journal:  BMJ       Date:  2006-08-05

Review 2.  The treatment of varicose veins.

Authors:  S Subramonia; T A Lees
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

3.  Uncomplicated varicose vein surgery in the UK--a postcode lottery?

Authors:  M K Nasr; J S Budd; M Horrocks
Journal:  Ann R Coll Surg Engl       Date:  2008-09       Impact factor: 1.891

4.  Treatment Patterns and Outcomes in Patients with Varicose Veins.

Authors:  Rajiv Mallick; Aditya Raju; Chelsey Campbell; Rashad Carlton; David Wright; Kimberly Boswell; Michael Eaddy
Journal:  Am Health Drug Benefits       Date:  2016-11

5.  Varicose veins: role of mechanotransduction of venous hypertension.

Authors:  Hussein M Atta
Journal:  Int J Vasc Med       Date:  2012-02-12

6.  Histological and Immunofluorescent Analysis of a Large Tributary of the Great Saphenous Vein Treated with a 1920 nm Endovenous Laser: Preliminary Findings.

Authors:  H F Ashpitel; E B Dabbs; J L Nemchand; R M La Ragione; F J Salguero; M S Whiteley
Journal:  EJVES Short Rep       Date:  2018-04-18

7.  Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system.

Authors:  Alexander Kuhlmann; Anne Prenzler; Jan Hacker; J-Matthias Graf von der Schulenburg
Journal:  Health Econ Rev       Date:  2013-04-03

8.  Modulation of circulating cytokine-chemokine profile in patients affected by chronic venous insufficiency undergoing surgical hemodynamic correction.

Authors:  Veronica Tisato; Giorgio Zauli; Sergio Gianesini; Erica Menegatti; Laura Brunelli; Roberto Manfredini; Paolo Zamboni; Paola Secchiero
Journal:  J Immunol Res       Date:  2014-03-25       Impact factor: 4.818

9.  Factors associated with recurrence of varicose veins after thermal ablation: results of the recurrent veins after thermal ablation study.

Authors:  R G Bush; P Bush; J Flanagan; R Fritz; T Gueldner; J Koziarski; K McMullen; G Zumbro
Journal:  ScientificWorldJournal       Date:  2014-01-27

10.  Mechanochemical endovenous Ablation versus RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA): study protocol for a randomized controlled trial.

Authors:  Ramon R J P van Eekeren; Doeke Boersma; Suzanne Holewijn; Anco Vahl; Jean Paul p m de Vries; Clark J Zeebregts; Michel M P J Reijnen
Journal:  Trials       Date:  2014-04-11       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.